104 related articles for article (PubMed ID: 2701727)
1. Therapy of chronic myelogenous leukaemia with interferons.
Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Th1 cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha.
Reuben JM; Lee BN; Johnson H; Fritsche H; Kantarjian HM; Talpaz M
Clin Cancer Res; 2000 May; 6(5):1671-7. PubMed ID: 10815885
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapy of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Gutterman J
Oncology (Williston Park); 1987 Sep; 1(7):35-40, 48-9, 52. PubMed ID: 3152810
[TBL] [Abstract][Full Text] [Related]
4. [One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Kobayashi Y; Kimura S; Tanaka K; Kimura S; Wada K; Ozawa M; Maruo N; Kondo M
Rinsho Ketsueki; 1990 Jul; 31(7):1013-6. PubMed ID: 2214181
[TBL] [Abstract][Full Text] [Related]
5. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
Nese M; de Bellis R; Urtiarte R; Di Landro J
Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
8. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
9. [Interferon-alpha therapy in chronic myeloid leukemia].
Lutz D
Wien Med Wochenschr; 1993; 143(16-17):416-9. PubMed ID: 8273364
[TBL] [Abstract][Full Text] [Related]
10. [Interferon therapy for chronic myelogenous leukemia].
Shibata A; Hashimoto S
Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
[TBL] [Abstract][Full Text] [Related]
11. [Value of interferon-alpha in treatment of chronic myeloid leukemia].
Thaler J
Acta Med Austriaca; 1993; 20(3):65-9. PubMed ID: 8368048
[TBL] [Abstract][Full Text] [Related]
12. [Chronic myelogenous leukemia maintained in remission by interferon alpha presenting with bladder cancer].
Kobayashi H; Ogawa T
Rinsho Ketsueki; 1989 Jul; 30(7):1093-4. PubMed ID: 2810796
[TBL] [Abstract][Full Text] [Related]
13. Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy.
Opalka B; Wandl U; Beer U; Roggenbuck U; Kloke O; Niederle N
Leukemia; 1991 Jun; 5(6):452-6. PubMed ID: 2056769
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
15. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia].
Iványi JL; Marton E; Kereskai L; Kiss Z; Pajor L
Orv Hetil; 2000 Nov; 141(47):2527-33. PubMed ID: 11143285
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience of antibodies to interferon-alpha during treatment of chronic myeloid leukemia.
Russo D; Candoni A; Grattoni R
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S47-9. PubMed ID: 9241616
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies of natural interferon alpha (HLBI) in chronic myelogenous leukemia--a multi-institutional cooperative study in Japan].
Koyama S; Moriyama Y; Shibata A; Miura Y; Abe T; Asano S; Miyazaki T; Miura A; Kariyone S; Toyama K
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2959-66. PubMed ID: 3052301
[TBL] [Abstract][Full Text] [Related]
18. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
Li YF; Deng ZK; Xuan HB; Zhu JB; Ding BH; Liu XN; Chen BA
Chin Med J (Engl); 2009 Jun; 122(12):1413-7. PubMed ID: 19567163
[TBL] [Abstract][Full Text] [Related]
19. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
[No Abstract] [Full Text] [Related]
20. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
